Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome

Haishan Chen,* Chongxiang Xiong, Xiaofei Shao,* Jing Ning, Peichun Gao, Hua Xiao, Yunying Chen, Ziliang Zou, Guobao Hong, Xiaolin Li, Mengjiao Shao, Jieli Sheng, Xingyan Yang, Xu You, Hequn Zou Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, Pe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen H, Xiong C, Shao X, Ning J, Gao P, Xiao H, Chen Y, Zou Z, Hong G, Li X, Shao M, Sheng J, Yang X, You X, Zou H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/3048cb2b3eca41a98a91175f5ec34bbc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3048cb2b3eca41a98a91175f5ec34bbc
record_format dspace
spelling oai:doaj.org-article:3048cb2b3eca41a98a91175f5ec34bbc2021-12-02T00:46:09ZLymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome1178-7007https://doaj.org/article/3048cb2b3eca41a98a91175f5ec34bbc2019-10-01T00:00:00Zhttps://www.dovepress.com/lymphocyte-to-high-density-lipoprotein-ratio-as-a-new-indicator-of-inf-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Haishan Chen,* Chongxiang Xiong, Xiaofei Shao,* Jing Ning, Peichun Gao, Hua Xiao, Yunying Chen, Ziliang Zou, Guobao Hong, Xiaolin Li, Mengjiao Shao, Jieli Sheng, Xingyan Yang, Xu You, Hequn Zou Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hequn ZouDepartment of Nephrology, The Third Affiliated Hospital, Southern Medical University, 183 Zhongshan West Avenue, Tianhe District, Guangzhou 510630, People’s Republic of ChinaEmail Hequnzou@hotmail.comPurpose: Metabolic syndrome (MetS), which is a global public health problem, is a state of chronic low-grade inflammation. This study looked at the changes in hematological parameters and the predictive value of the lymphocyte to high-density lipoprotein cholesterol (HDL-C) ratio (LHR) as a new index in subjects with and without MetS in coastal cities in southern China.Patients and methods: In this cross-sectional study, there were 852 participants (n = 598 with MetS and n = 254 without MetS). MetS was defined in accordance with the National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATP III) criteria.Results: MetS was positively correlated with white blood cell count, total lymphocyte count, neutrophil count, red blood cell count, hematocrit, hemoglobin, and high-sensitivity C-reactive protein levels (p<0.05). In addition, there was a positive correlation between LHR and the number of metabolic risk factors for MetS. In a logistic regression analysis, LHR (odds ratio: 4.117; 95% CI: 2.766–6.309; p<0.001) was an independent predictor of MetS. When a receiver operating characteristic (ROC) curve analysis was used to assess the value of LHR for predicting MetS, the area under the curve yielded a cut-off value of 1.657, with a sensitivity of 65% and a specificity of 64% (p<0.0001).Conclusion: In summary, MetS can involve changes in blood parameters, and LHR may be a useful marker of inflammation to assess the presence and severity of MetS.Keywords: inflammation, marker, metabolic syndrome, lymphocyte to high-density lipoprotein cholesterol ratioChen HXiong CShao XNing JGao PXiao HChen YZou ZHong GLi XShao MSheng JYang XYou XZou HDove Medical PressarticleInflammationmarkermetabolic syndromelymphocyte to high-density lipoprotein cholesterol ratioSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 2117-2123 (2019)
institution DOAJ
collection DOAJ
language EN
topic Inflammation
marker
metabolic syndrome
lymphocyte to high-density lipoprotein cholesterol ratio
Specialties of internal medicine
RC581-951
spellingShingle Inflammation
marker
metabolic syndrome
lymphocyte to high-density lipoprotein cholesterol ratio
Specialties of internal medicine
RC581-951
Chen H
Xiong C
Shao X
Ning J
Gao P
Xiao H
Chen Y
Zou Z
Hong G
Li X
Shao M
Sheng J
Yang X
You X
Zou H
Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
description Haishan Chen,* Chongxiang Xiong, Xiaofei Shao,* Jing Ning, Peichun Gao, Hua Xiao, Yunying Chen, Ziliang Zou, Guobao Hong, Xiaolin Li, Mengjiao Shao, Jieli Sheng, Xingyan Yang, Xu You, Hequn Zou Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hequn ZouDepartment of Nephrology, The Third Affiliated Hospital, Southern Medical University, 183 Zhongshan West Avenue, Tianhe District, Guangzhou 510630, People’s Republic of ChinaEmail Hequnzou@hotmail.comPurpose: Metabolic syndrome (MetS), which is a global public health problem, is a state of chronic low-grade inflammation. This study looked at the changes in hematological parameters and the predictive value of the lymphocyte to high-density lipoprotein cholesterol (HDL-C) ratio (LHR) as a new index in subjects with and without MetS in coastal cities in southern China.Patients and methods: In this cross-sectional study, there were 852 participants (n = 598 with MetS and n = 254 without MetS). MetS was defined in accordance with the National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATP III) criteria.Results: MetS was positively correlated with white blood cell count, total lymphocyte count, neutrophil count, red blood cell count, hematocrit, hemoglobin, and high-sensitivity C-reactive protein levels (p<0.05). In addition, there was a positive correlation between LHR and the number of metabolic risk factors for MetS. In a logistic regression analysis, LHR (odds ratio: 4.117; 95% CI: 2.766–6.309; p<0.001) was an independent predictor of MetS. When a receiver operating characteristic (ROC) curve analysis was used to assess the value of LHR for predicting MetS, the area under the curve yielded a cut-off value of 1.657, with a sensitivity of 65% and a specificity of 64% (p<0.0001).Conclusion: In summary, MetS can involve changes in blood parameters, and LHR may be a useful marker of inflammation to assess the presence and severity of MetS.Keywords: inflammation, marker, metabolic syndrome, lymphocyte to high-density lipoprotein cholesterol ratio
format article
author Chen H
Xiong C
Shao X
Ning J
Gao P
Xiao H
Chen Y
Zou Z
Hong G
Li X
Shao M
Sheng J
Yang X
You X
Zou H
author_facet Chen H
Xiong C
Shao X
Ning J
Gao P
Xiao H
Chen Y
Zou Z
Hong G
Li X
Shao M
Sheng J
Yang X
You X
Zou H
author_sort Chen H
title Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
title_short Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
title_full Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
title_fullStr Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
title_full_unstemmed Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
title_sort lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/3048cb2b3eca41a98a91175f5ec34bbc
work_keys_str_mv AT chenh lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT xiongc lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT shaox lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT ningj lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT gaop lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT xiaoh lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT cheny lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT zouz lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT hongg lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT lix lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT shaom lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT shengj lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT yangx lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT youx lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
AT zouh lymphocytetohighdensitylipoproteinratioasanewindicatorofinflammationandmetabolicsyndrome
_version_ 1718403483632140288